PRECLINICAL CHARACTERIZATION OF ABI-4334, A NOVEL, HIGHLY POTENT CORE INHIBITOR FOR THE TREATMENT OF CHRONIC HEPATITIS B VIRUS INFECTION

被引：0
|
作者：
Xu, Xiang [1 ]
Shen, Michael [1 ]
Guo, Lida [1 ]
Tang, Ariel [1 ]
Unchwaniwala, Nuruddin [1 ]
Heckrodt, Thilo J. [1 ]
Zhong, Min [1 ]
Walker, Michael [1 ]
Perron, Michel [2 ]
Delaney, William E. [1 ]
Kitrinos, Kathryn [1 ]
机构：
[1] Assembly Biosci, San Francisco, CA USA
[2] Assembly Biosci, Discovery Biol, San Francisco, CA USA
来源：
HEPATOLOGY | 2021年 / 74卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LP4
引用
收藏
页码：1394A / 1395A
页数：2
相关论文
共 50 条
  • [1] ABI-4334, A NOVEL HEPATITIS B VIRUS CORE INHIBITOR, ACCELERATES CAPSID ASSEMBLY AND INHIBITS CCCDNA FORMATION VIA MULTIPLE PATHWAYS
    Unchwaniwala, Nuruddin
    Pionek, Karolyn
    Loeb, Daniel D.
    Delaney, William E.
    Kitrinos, Kathryn
    [J]. HEPATOLOGY, 2022, 76 : S248 - S248
  • [2] Preclinical characterization of a novel potent core protein assembly modulator for the treatment of chronic hepatitis B viral infection
    Dunkoksung, Wilasinee
    Udomnilobol, Udomsak
    Ruengsatra, Tanachote
    Chauypen, Natthaya
    Prueksaritanont, Thomayant
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 200
  • [3] ABI-4334, a novel inhibitor of hepatitis B virus core protein, promotes formation of empty capsids and prevents covalently closed circular DNA formation by disruption of incoming capsids
    Unchwaniwala, Nuruddin
    Delaney, William
    Kitrinos, Kathryn M.
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S844 - S845
  • [4] Preclinical Profile and Characterization of the Hepatitis B Virus Core Protein Inhibitor ABI-H0731
    Huang, Qi
    Cai, Dawei
    Yan, Ran
    Li, Lichun
    Zong, Yuhua
    Guo, Lida
    Mercier, Alexandre
    Zhou, Yi
    Tang, Ariel
    Henne, Kirk
    Colonno, Richard
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (11)
  • [5] PRECLINICAL CHARACTERIZATION OF POTENT CORE PROTEIN ASSEMBLY MODULATORS FOR THE TREATMENT OF CHRONIC HEPATITIS B
    Huang, Q.
    Mercier, A.
    Zhou, Y.
    Henne, K.
    Kumar, G. Renuka
    Sun, S.
    Guo, L.
    Liu, J.
    Zong, Y.
    Sun, T.
    Nabel, K.
    Li, P. -C.
    Mahon, C.
    Chen, G.
    Bures, M.
    Li, L.
    May, E.
    Connelly, E.
    Deer, J.
    Katen, S.
    Francis, S.
    Turner, W. W.
    Zlotnick, A.
    Arnold, L. D.
    Lopatin, U.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S584 - S584
  • [6] Discovery and preclinical profile of VNRX-9945, a potent, broadly active core protein inhibitor for the treatment of hepatitis B virus (HBV) infection
    Coburn, Glen
    Liu, Bin
    Benetatos, Christopher
    Yao, Jiangchao
    Boyd, Steve
    Haimowitz, Tom
    Condon, Stephen
    Drager, Tony
    Hart, Susan Emeigh
    Pevear, Daniel
    Burns, Christopher
    [J]. JOURNAL OF HEPATOLOGY, 2021, 75 : S748 - S748
  • [7] PRECLINICAL CHARACTERIZATION OF A NOVEL CLASS OF HIGHLY POTENT SMALL MOLECULE HEPATITIS B AND D VIRUS ENTRY INHIBITORS
    Contreras, Heidi
    Azimova, Dinara
    Tan, Joseph
    Unchwaniwala, Nuruddin
    Guo, Lida
    Shen, Michael
    Yu, Jiaxin
    Windisch, Marc P.
    Xu, Xiang
    Perron, Michel
    Walker, Michael
    Delaney, William
    Zhong, Min
    [J]. HEPATOLOGY, 2022, 76 : S259 - S259
  • [8] The safety and pharmacokinetics of ABI-4334, a novel next-generation HBV core inhibitor: interim results from a phase 1 study in healthy volunteers
    Gane, Edward J.
    Schwabe, Christian
    Liu, Jieming
    Stamm, Luisa M.
    Kitrinos, Kathryn M.
    Knox, Steven J.
    Anderson, Michele
    Wang, Grace
    Zomorodi, Katie
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S1161 - S1162
  • [9] Characterization of a Novel Capsid Assembly Modulator for the Treatment of Chronic Hepatitis B Virus Infection
    Burdette, Dara
    Hyrina, Anastasia
    Song, Zhijuan
    Beran, Rudolf K.
    Cheung, Tara
    Gilmore, Sarah
    Kobayashi, Tetsuya
    Li, Li
    Liu, Yang
    Niedziela-Majka, Anita
    Medley, Jonathan
    Mehra, Upasana
    Morganelli, Philip
    Novikov, Nikolai
    Niu, Congrong
    Tam, Danny
    Tang, Jennifer
    Wang, Jianhong
    Yue, Qin
    Fletcher, Simon P.
    Holdorf, Meghan M.
    Delaney, William E.
    Feierbach, Becket
    Lazerwith, Scott
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (01)
  • [10] Preclinical Characterization of GLS4, an Inhibitor of Hepatitis B Virus Core Particle Assembly
    Wu, Guoyi
    Liu, Bo
    Zhang, Yingjun
    Li, Jing
    Arzumanyan, Alla
    Clayton, Marcia M.
    Schinazi, Raymond F.
    Wang, Zhaohe
    Goldmann, Siegfried
    Ren, Qingyun
    Zhang, Faxhou
    Feitelson, Mark A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (11) : 5344 - 5354
12345